55 results
8-K
EQ
Equillium Inc
22 Feb 24
Other Events
6:08am
Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum bid price
8-K
EX-99.1
EQ
Equillium Inc
16 Oct 23
Regulation FD Disclosure
8:05am
Consultation Service, Department of Dermatology Brigham and Women’s Hospital EQ101: A First-in-Class Tri-Specific Inhibitor of IL-2, IL-9 & IL-15 … Medical School Director, Inpatient Consultation Service, Department of Dermatology Brigham and Women’s Hospital
Question 1 How are you treating patients
8-K
EX-1.1
652c3ic3513zs7y5dt0
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
PRE 14A
4d0p nmk9t3k3l74
31 Mar 23
Preliminary proxy
4:02pm
424B3
0u40 2uil0609otse
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
l0ov04dlxvf9
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
mhl wah6j
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
dv6h8ue
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
3ep o05r51nthw2u2qt3
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K/A
EX-99.1
58dw6ma0epz9hhn0348
2 May 22
Financial Statements and Exhibits
1:19pm